A Reuters news story (originated by the journal Urology) explains how obesity makes it harder for the PSA test to do what it's supposed to do ... detect prostate cancer. The prostate-specific antigen test (or PSA for short) is the common method used to detect prostate cancer in men. Prostate-specific antigen ...

Yessir. We love our red meat in this country. We love our rib eye steaks, and our beef ribs, and our double beef burgers, and ... you get the picture. In fact, we eat more red meat here in the United States than any other country in the world. It is ...

Unlike normal blog postings dealing with Choices, Ethics, and Consequences - my topics as a professional motivational speaker - it seemed appropriate today to speak of my complete recovery from prostate cancer hoping that it might help others who are faced with decisions on prostate cancer treatment. Discovering I had prostate ...

Prostate Cancer Treatment Centre Receives Funding for Clinical Trials Clinical Trial Aimed to Supplement Current Research Findings on the Treatment of Localized Prostate Cancer TORONTO, Nov. 14 /PRNewswire/ -- A Canadian study on High Intensity Focused Ultrasound therapy with the Sonablate(R) 500 - a Health Canada approved treatment for localized prostate cancer - is ...

SARASOTA, Fla., Nov. 5 /PRNewswire/ -- JM, a 71 year old business executive from Tennessee, had a negative biopsy using gray scale ultrasound despite a PSA of 7.1. The following year, the PSA rose to 11.5 prompting a second biopsy that was negative despite adding Color Flow Doppler Ultrasound. At this point, the patient and ...

Safeway Inc. and the Prostate Cancer Foundation to Fund Landmark Prostate Cancer Research Collaboration S.T.A.R Program Brings Together Researchers from North America's Leading Prostate Cancer Centers WASHINGTON, Nov. 15 /PRNewswire/ -- Safeway Inc. and the Prostate Cancer Foundation today announced they will collectively donate $6 million to fund the S.T.A.R. Program (for Special Team Amplification ...

WEBWIRE – Wednesday, October 24, 2007 ANN ARBOR, MI – The University of Michigan Center for Translational Pathology and The Prostate Cancer Foundation (PCF) and have joined forces to raise $2 million to accelerate research towards developing targeted therapies for prostate cancer. The Prostate Cancer Foundation, the world’s largest philanthropic source ...

October 1, 2007 STANDARD TREATMENT FOR PROSTATE CANCER MAY ENCOURAGE SPREAD OF DISEASE A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins researchers suggests. Although the finding could ...

Prostate Cancer Research Institute adds Bernhoff A. Dahl, M.D. to their Helpline staff. Bangor, ME 04496 -- October 18 2007 -- The Prostate Cancer Research Institute (PCRI) was founded in 1996 by internationally recognized prostate-focused oncologists Stephen B. Strum, M.D. and Mark C. Scholz, M.D. with support from the Daniel ...

Shrinkage of Prostate Led to Overestimation of Cancer Risk in Trial Reanalysis of data from the Prostate Cancer Prevention Trial of a chemopreventive agent for prostate cancer shows that the excess prevalence of high-grade prostate cancer in the drug-treated group may be attributable to shrinkage of the prostate at the time ...